全球經導管器械市場規模、佔有率、成長分析、依產品（經導管栓塞和閉塞器械、經導管替代器材）、依應用（心血管、腫瘤）- 2024-2031 年產業預測

Global Transcatheter Devices Market Size, Share, Growth Analysis, By Product(Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices), By Application(Cardiovascular, Oncology) - Industry Forecast 2024-2031

出版日期: 2024年03月04日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球經導管器材市場規模為123.2億美元，預計將從2023年的139.9億美元成長到2031年的386.6億美元，預測期間（2024-2031年）複合CAGR為13.55%。

全球經導管設備市場在醫療保健領域呈現有趣的變化。這些設備變得越來越受歡迎，因為它們提供了一種用更小的切口進行手術的方法，這意味著患者的不適感更少，恢復更快。它們可用於治療各種健康問題，例如心臟問題，而無需進行傳統的開放性手術。該市場正在成長，因為越來越多的人變老並患有慢性病，醫療技術越來越好。人們，包括醫生和患者，都希望得到能夠幫助他們更快康復並減少術後問題的治療方法，而經導管設備正好符合這項要求。然而，市場的成長也面臨著課題，例如有關使用設備的規則、使用它們獲得報酬以及需要特殊培訓才能正確使用它們。儘管如此，關於如何改進這些設備的持續研究和新想法，以及醫生和設備製造商之間的合作，將塑造經導管設備全球市場的未來。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名玩家比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

CryoLife, Inc. (US)
Edwards Lifesciences Corporation (US)
Abbott (US)
Boston Scientific Corporation (US)
enaValve Technology, Inc. (US)
Terumo Corporation (Japan)
Neovasc Inc. (Canada)
Meril Life Sciences Pvt. Ltd. (India)
Symetis SA (Switzerland)
Venus Medtech (Hangzhou) Inc. (China)
Medtronic plc (Ireland)
WL Gore & Associates (US)
JenaValve Technology, Inc. (US)
Xeltis AG (Switzerland)
LivaNova PLC (UK)
Endologix Inc. (US)
B. Braun Melsungen AG (Germany)
Biosensors International Group, Ltd. (Singapore)
Direct Flow Medical, Inc. (US)
Transcatheter Technologies GmbH (Germany)

簡介目錄

Product Code: SQMIG35A2584

Global Transcatheter Devices Market size was valued at USD 12.32 billion in 2022 and is poised to grow from USD 13.99 billion in 2023 to USD 38.66 billion by 2031, growing at a CAGR of 13.55% in the forecast period (2024- 2031).

The global market for transcatheter devices is showing interesting changes in the healthcare field. These devices are becoming more popular because they offer a way to perform surgeries with smaller incisions, which means less discomfort and faster recovery for patients. They're used for various health issues, like heart problems, without needing to do traditional open surgeries. The market is growing because more people are getting older and having chronic illnesses, and medical technology is getting better. People, including doctors and patients, want treatments that help them recover faster and have fewer problems afterward, and transcatheter devices fit the bill. However, there are challenges to the market's growth, like rules about using the devices, getting paid for using them, and needing special training to use them properly. Still, ongoing research and new ideas about how to make these devices better, along with cooperation between doctors and device makers, will shape the future of the global market for transcatheter devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Devices Market Segmental Analysis

The global Transcatheter Devices Market is segmented on the basis of Application, Product, and Region. By Application, the market is segmented into Cardiovascular, Oncology, Neurology, Urology, and Others. By Product, the market is segmented into Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices, Transcatheter Repair Devices. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transcatheter Devices Market

As medical technology advances, there's a bigger focus on procedures that make patients less uncomfortable, shorten hospital stays, and speed up recovery times. Transcatheter devices, like stents, valves, and embolization devices, are vital for performing less invasive procedures in different medical fields. These devices let doctors reach specific areas in the body through small cuts, meaning they don't need to do traditional open surgeries. Because patients want procedures that help them recover faster with fewer problems, the use of transcatheter devices is increasing. This trend is pushing innovation and changing how treatments are done in healthcare.

Restraints in the Global Transcatheter Devices Market

Creating and selling these new medical devices usually involves a lot of clinical trials and getting approval from regulators. Transcatheter procedures are complicated, and using new technology can have risks, so it's important to carefully check them to keep patients safe. Dealing with different rules in different places can slow down getting products out and make it more expensive for companies. Because of this, these rules can slow down how quickly new devices are made and get into the market, which is a big restraint for the global market for transcatheter devices.

Market Trends of the Global Transcatheter Devices Market

TAVR (Transcatheter Aortic Valve Replacement) has become increasingly popular as a less invasive option compared to traditional open-heart surgery for treating aortic valve diseases, especially in older patients and those at high risk during surgery. This trend is driven by the procedure's benefits of faster recovery, shorter hospital stays, and fewer complications, which align with patients' preferences for less invasive treatments. With the growing number of elderly patients and advancements in TAVR techniques, its use is expanding across different regions. Additionally, ongoing research and development are improving TAVR technologies, making them more widely applicable and ensuring better patient outcomes in the global transcatheter devices market.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Transcatheter Devices Market by Product

Market Overview
Transcatheter Embolization and Occlusion Devices
Transcatheter Replacement Devices
and Transcatheter Repair Devices

Global Transcatheter Devices Market by Application

Market Overview
Cardiovascular
Oncology
Neurology
Urology
and Others

Global Transcatheter Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

CryoLife, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
enaValve Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neovasc Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Symetis SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Venus Medtech (Hangzhou) Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W.L. Gore & Associates (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JenaValve Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xeltis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Direct Flow Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transcatheter Technologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments